BioCentury | Jan 6, 2017
Company News

Protagen, Novartis deal

...to inquiries. Protagen AG , Dortmund, Germany Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Autoimmune Shannon Lehnbeuter Novartis AG Protagen AG SeroTag...
BioCentury | Aug 22, 2016
Company News

Protagen, Werfen deal

...which Inova will add to its assay portfolio. The companies declined to disclose additional details. Protagen AG...
BioCentury | Jun 20, 2016
Company News

Protagen sales and marketing update

...antibodies for the bicaudal D homolog 2 (BICD2) protein. The assays have CE Mark approval. Protagen AG...
BioCentury | Dec 21, 2015
Company News

Protagen, Mikrogen deal

...the diagnostic. Protagen declined to disclose financial terms, and Mikrogen did not respond to inquiries. Protagen AG...
BioCentury | Dec 22, 2014
Financial News

Protagen completes venture financing

...Venture financing Raised: Not disclosed Investors: Qiagen N.V. ; MIG Funds; NRW.Bank; company management Note: Protagen...
BioCentury | Sep 1, 2014
Company News

Protagen sales and marketing update

...in the EU and North America to research scleroderma. The qualitative ELISA-based test kit uses Protagen’s...
...use only and takes about two and a half hours to run eight plasma samples. Protagen...
...disease detection by early 3Q15. The company declined to disclose the price of the test. Protagen AG...
BioCentury | Dec 9, 2013
Company News

Protagen, Pfizer deal

...to identify autoantibody biomarkers. Pfizer declined to disclose details, and Protagen could not be reached. Protagen AG...
BioCentury | Dec 12, 2011
Company News

Protagen, Bayer deal

...Protagen and Bayer's Bayer Healthcare Pharmaceuticals business partnered to clinically validate diagnostic biomarkers in endometriosis. Protagen...
...the clinical validation. Last year, the companies partnered to discover biomarkers to diagnose endometriosis using Protagen's...
...UNIarray identifies auto-antibody signatures in blood. Details were not disclosed (see BioCentury, June 28, 2010). Protagen AG...
BioCentury | Aug 8, 2011
Company News

Protagen, SuppreMol deal

...treat idiopathic thrombocytopenic purpura (ITP), with data from the Phase Ib portion expected in 1Q12. Protagen AG...
BioCentury | Apr 4, 2011
Company News

Biogen Idec, Protagen deal

...worldwide sales of $2.5 billion for the immune modulator. Biogen Idec Inc. (NASDAQ:BIIB), Weston, Mass. Protagen AG...
Items per page:
1 - 10 of 37
BioCentury | Jan 6, 2017
Company News

Protagen, Novartis deal

...to inquiries. Protagen AG , Dortmund, Germany Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Autoimmune Shannon Lehnbeuter Novartis AG Protagen AG SeroTag...
BioCentury | Aug 22, 2016
Company News

Protagen, Werfen deal

...which Inova will add to its assay portfolio. The companies declined to disclose additional details. Protagen AG...
BioCentury | Jun 20, 2016
Company News

Protagen sales and marketing update

...antibodies for the bicaudal D homolog 2 (BICD2) protein. The assays have CE Mark approval. Protagen AG...
BioCentury | Dec 21, 2015
Company News

Protagen, Mikrogen deal

...the diagnostic. Protagen declined to disclose financial terms, and Mikrogen did not respond to inquiries. Protagen AG...
BioCentury | Dec 22, 2014
Financial News

Protagen completes venture financing

...Venture financing Raised: Not disclosed Investors: Qiagen N.V. ; MIG Funds; NRW.Bank; company management Note: Protagen...
BioCentury | Sep 1, 2014
Company News

Protagen sales and marketing update

...in the EU and North America to research scleroderma. The qualitative ELISA-based test kit uses Protagen’s...
...use only and takes about two and a half hours to run eight plasma samples. Protagen...
...disease detection by early 3Q15. The company declined to disclose the price of the test. Protagen AG...
BioCentury | Dec 9, 2013
Company News

Protagen, Pfizer deal

...to identify autoantibody biomarkers. Pfizer declined to disclose details, and Protagen could not be reached. Protagen AG...
BioCentury | Dec 12, 2011
Company News

Protagen, Bayer deal

...Protagen and Bayer's Bayer Healthcare Pharmaceuticals business partnered to clinically validate diagnostic biomarkers in endometriosis. Protagen...
...the clinical validation. Last year, the companies partnered to discover biomarkers to diagnose endometriosis using Protagen's...
...UNIarray identifies auto-antibody signatures in blood. Details were not disclosed (see BioCentury, June 28, 2010). Protagen AG...
BioCentury | Aug 8, 2011
Company News

Protagen, SuppreMol deal

...treat idiopathic thrombocytopenic purpura (ITP), with data from the Phase Ib portion expected in 1Q12. Protagen AG...
BioCentury | Apr 4, 2011
Company News

Biogen Idec, Protagen deal

...worldwide sales of $2.5 billion for the immune modulator. Biogen Idec Inc. (NASDAQ:BIIB), Weston, Mass. Protagen AG...
Items per page:
1 - 10 of 37